R. Winters Chad's Insider Trades & SAST Disclosures
R. Winters Chad's most recent trade in West Pharmaceutical Services, Inc. was a trade of 822 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. Winters Chad.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 822 | 822 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 356 | 356 | - | - | Rst. Stock Unit | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 211.13 per share. | 18 Feb 2025 | 82 | 1,390 (0%) | 0% | 211.1 | 17,313 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.67 per share. | 18 Feb 2025 | 27 | 1,363 (0%) | 0% | 216.7 | 5,850 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 358.82 per share. | 11 Mar 2024 | 815 | 1,308 (0%) | 0% | 358.8 | 292,436 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 675 | 896 | - | - | Stock Options (Right to Buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.22 per share. | 11 Mar 2024 | 675 | 2,123 (0%) | 0% | 173.2 | 116,924 | Common Stock |
| West Pharmaceutical Servic... | R. Winters Chad | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 1,020 | 1,020 | - | - | Stock Options (Right to Buy) | |
| West Pharmaceutical Servic... | R. Chad Winters | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 179 | 1,448 (0%) | 0% | 0 | Common Stock | |
| West Pharmaceutical Servic... | Winters Chad R. | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 349.00 per share. | 04 Dec 2023 | 1,013 | 1,269 (0%) | 0% | 349.0 | 353,541 | Common Stock |
| West Pharmaceutical Servic... | Winters R. Chad | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2023 | 456 | 0 | - | - | Stock Options (Right to Buy) | |
| West Pharmaceutical Servic... | R. Winters Chad | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 143.43 per share. | 04 Dec 2023 | 456 | 1,941 (0%) | 0% | 143.4 | 65,404 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2023 | 341 | 1,571 | - | - | Stock Options (Right to Buy) | |
| West Pharmaceutical Servic... | Winters R. Chad | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.22 per share. | 04 Dec 2023 | 341 | 2,282 (0%) | 0% | 173.2 | 59,068 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 872 | 456 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 143.43 per share. | 30 May 2023 | 872 | 2,320 (0%) | 0% | 143.4 | 125,071 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 339.51 per share. | 30 May 2023 | 872 | 1,448 (0%) | 0% | 339.5 | 296,053 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 368.50 per share. | 05 May 2023 | 10 | 1,448 (0%) | 0% | 368.5 | 3,685 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 1,012 | 1,012 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 21 Feb 2023 | 476 | 1,458 (0%) | 0% | 306.7 | 145,980 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 225.51 per share. | 31 Oct 2022 | 47 | 982 (0%) | 0% | 225.5 | 10,599 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 314.80 per share. | 05 May 2022 | 10 | 1,062 (0%) | 0% | 314.8 | 3,148 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 1,036 | 1,036 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 369.13 per share. | 22 Feb 2022 | 414 | 1,072 (0%) | 0% | 369.1 | 152,820 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 429.87 per share. | 29 Oct 2021 | 47 | 658 (0%) | 0% | 429.9 | 20,204 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 328.60 per share. | 05 May 2021 | 10 | 705 (0%) | 0% | 328.6 | 3,286 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 261.62 per share. | 12 Mar 2021 | 170 | 714 (0%) | 0% | 261.6 | 44,475 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 1,388 | 1,388 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.23 per share. | 29 Oct 2020 | 47 | 544 (0%) | 0% | 275.2 | 12,936 | Common Stock |
| West Pharmaceutical Servic... | Chad R. Winters | VP, CAO & Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 102 | 591 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges